Financhill
Back

Myriad Genetics Quote, Financials, Valuation and Earnings

Myriad Genetics Price Quote

$19.70
-0.27 (-1.35%)
(Updated: May 7, 2024 at 1:20 PM ET)

Myriad Genetics Key Stats

Sell
49
Myriad Genetics (MYGN) is a Sell

Day range:
$19.47 - $20.20
52-week range:
$13.82 - $24.21
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
2.20
P/B ratio:
2.29%

Volume:
590.2K
Avg. volume:
615K
1-year change:
3.53%
Market cap:
$1.8B
Revenue:
$753.2M
EPS:
$-3.2

How Much Does Myriad Genetics Make?

Is Myriad Genetics Growing As A Company?

  • What Is Myriad Genetics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.11%
  • What Is Myriad Genetics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Myriad Genetics Stock Price Performance

  • Did Myriad Genetics Stock Go Up Last Month?
    Myriad Genetics share price went down by -1.43% last month
  • Did MYGN's Share Price Rise Over The Last Year?
    MYGN share price rose by 3.53% over the past 1 year

What Is Myriad Genetics 52-Week High & Low?

Myriad Genetics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Myriad Genetics?

  • How Much Debt Does Myriad Genetics Have?
    Total long term debt quarterly is $38.5M
  • How Much Cash Does Myriad Genetics Have?
    Cash and short term investments quarterly total is $140.9M
  • What Is Myriad Genetics’s Book Value Per Share?
    Book value per share is 8.71

Is Myriad Genetics Cash Flow Positive?

  • What Is MYGN Cash Flow From Operations?
    Cash flow from operations (TTM) is -$110.9M
  • What Is Myriad Genetics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $152.9M
  • What Is Myriad Genetics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $31.9M

Myriad Genetics Return On Invested Capital

  • Is Management Doing A Good Job?
    MYGN return on invested capital is -32.6%
  • What Is Myriad Genetics Return On Assets?
    ROA measures how assets are converting to revenues and is -22.5%
  • What Is MYGN Return On Equity?
    ROE is a measure of profitability and is -33.56%

Myriad Genetics Earnings Date & Stock Price

Myriad Genetics Competitors

  • Who Are Myriad Genetics's Competitors?
    Below is a list of companies who compete with Myriad Genetics or are related in some way:
    • Asensus Surgical Inc (ASXC)
    • Perspective Therapeutics Inc (CATX)
    • Electromed Inc (ELMD)
    • Stryker Corp (SYK)
    • Xtant Medical Holdings Inc (XTNT)

Myriad Genetics Dividend Yield

Data Unavailable

Myriad Genetics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 214.22%
Revenue: 10.57% 1.01%

Analyst Recommendations

Buy Recommendations: 2
Hold Recommendations: 6
Sell Recommendations: 0
Price Target: 24.08
Upside from Last Price: 20.6%

Major Shareholders

  • How many MYGN shares are owned by institutional investors?
    149.2M MYGN shares are owned by institutional investors
  • How many MYGN shares are owned by insiders?
    7.2M MYGN shares are owned by insiders